Reuters logo
BRIEF-Endologix announces temporary hold on AFX to resolve a manufacturing issue
December 27, 2016 / 1:10 PM / 10 months ago

BRIEF-Endologix announces temporary hold on AFX to resolve a manufacturing issue

Dec 27 (Reuters) - Endologix Inc

* Endologix announces temporary hold on AFX to resolve a manufacturing issue

* Company expects temporary hold to be lifted for some sizes in near future

* AFX manufacturing issue is unrelated to manufacturing process for Nellix and Ovation, which continue to be available in approved markets

* Temporary hold on AFX is not related to any reported events from physicians

* “continue to see very good commercial clinical results with latest versions of AFX and AFX2” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below